Pharmacology and Therapeutics

Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary
Michele Fusaroli, Valentina Giunchi, Vera Battini, Stefano Puligheddu, Charles Khouri, Carla Carnovale, Emanuel Raschi, Elisabetta Poluzzi

medRxiv 2023.06.07.23291076; doi: https://doi.org/10.1101/2023.06.07.23291076

Add to Selected Citations
Pharmacogenetics of SGLT2 Inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker
Simeon I. Taylor, Hua-Ren Cherng, Zhinous Shahidzadeh Yazdi, May E. Montasser, Hilary B. Whitlatch, Braxton D. Mitchell, Alan R. Shuldiner, Elizabeth A. Streeten, Amber L. Beitelshees

medRxiv 2023.03.07.23286875; doi: https://doi.org/10.1101/2023.03.07.23286875

Add to Selected Citations
Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins
Mohd Anisul Karim, Bruno Ariano, Jeremy Schwartzentruber, Juan Maria Roldan-Romero, Edward Mountjoy, James Hayhurst, Annalisa Buniello, Elmutaz Shaikho Elhaj Mohammed, Miguel Carmona, Michael V Holmes, Chloe Robins, Praveen Surendran, Stephen Haddad, Robert A Scott, Andrew R. Leach, David Ochoa, Joseph Maranville, Ellen M. McDonagh, Ian Dunham, Maya Ghoussaini

medRxiv 2023.06.01.23290252; doi: https://doi.org/10.1101/2023.06.01.23290252

Add to Selected Citations
Explainable drug side effect prediction via biologically informed graph neural network
Tongtong Huang, Ko-Hong Lin, Rodrigo Machado-Vieira, Jair C Soares, Xiaoqian Jiang, Yejin Kim

medRxiv 2023.05.26.23290615; doi: https://doi.org/10.1101/2023.05.26.23290615

Add to Selected Citations
A Cannabidiol/Terpene Formulation That Increases Restorative Sleep in Insomniacs: A Double-Blind, Placebo-controlled, Randomized, Crossover Pilot Study
Michael Wang, Marcus Faust, Scott Abbott, Vikrant Patel, Eric Chang, John I. Clark, Nephi Stella, Paul J. Muchowski

medRxiv 2023.06.03.23290932; doi: https://doi.org/10.1101/2023.06.03.23290932

Add to Selected Citations
Depression events associated with proton-pump inhibitors in postmarketing drug surveillance data
Tigran Makunts, Haroutyun Joulfayan, Kenneth Ta, Ruben Abagyan

medRxiv 2023.06.03.23290931; doi: https://doi.org/10.1101/2023.06.03.23290931

Add to Selected Citations
USING MACHINE LEARNING OR DEEP LEARNING MODELS IN A HOSPITAL SETTING TO DETECT INAPPROPRIATE PRESCRIPTIONS: A SYSTEMATIC REVIEW
E. Johns, J. Godet, A. Alkanj, M. Beck, L. Dal Mas, B. Gourieux, E.-A. Sauleau, B. Michel

medRxiv 2023.06.01.23290818; doi: https://doi.org/10.1101/2023.06.01.23290818

Add to Selected Citations
Perception and satisfaction of pharmacists’ roles and services provided in University of Nigeria Nsukka
Judith Chinaecherem Azor, Adaobi Uchenna Mosanya, Blessing Onyinye Ukoha-Kalu

medRxiv 2023.05.28.23290645; doi: https://doi.org/10.1101/2023.05.28.23290645

Add to Selected Citations
Selenium supplementation and clinical outcomes: an umbrella review protocol
Adaobi Uchenna Mosanya, Ifeoma Umeh, Abba Khalid Abdullahi, Blessing Onyinye Ukoha-Kalu, Maxwell Ogochukwu Adibe, Carmen Sanmartin Grijalba

medRxiv 2023.05.26.23290575; doi: https://doi.org/10.1101/2023.05.26.23290575

Add to Selected Citations
National Increase but Pronounced Regional Disparities in Naloxone Prescribing to United States Medicaid and Medicare Patients
Christopher D. Manko, Mohamed S. Ahmed, Lavinia H. Harrison, Sree Kodavatiganti, Noelia Lugo, Jason O. Konadu, Farrin Khan, Carrie A. Massari, Tenisha K. Sealey, Maame Efua Addison, Celine N. Mbah, Kenneth L. McCall, Joseph B. Fraiman, Brian J. Piper

medRxiv 2023.05.17.23290119; doi: https://doi.org/10.1101/2023.05.17.23290119

Add to Selected Citations

Pharmacology and Therapeutics

Pages